The book is currently out of stock

More about the book
The book provides a comprehensive review of Parkinson's disease from both clinical and scientific perspectives, covering its preclinical course, symptomatology, and genetic factors. It explores various subtypes and their implications for pathology, alongside diagnostic tools and treatment strategies, including traditional and novel therapies focused on neuroprotection and neuroregeneration. A significant highlight is the discussion on budipine, a new antiparkinsonian drug that affects non-dopaminergic systems. The text emphasizes the ongoing challenges and unanswered questions in effectively treating Parkinson's disease.
Book purchase
Diagnosis and Treatment of Parkinsons Disease State of the Art, Horst Przuntek, Thomas Müller
- Language
- Released
- 1999
- product-detail.submit-box.info.binding
- (Paperback)
We’ll notify you via email once we track it down.
Payment methods
- Title
- Diagnosis and Treatment of Parkinsons Disease State of the Art
- Language
- English
- Authors
- Horst Przuntek, Thomas Müller
- Publisher
- Springer Vienna
- Released
- 1999
- Format
- Paperback
- Pages
- 236
- ISBN13
- 9783211832752
- Category
- Health / Medicine, Nature in general, Psychology
- Description
- The book provides a comprehensive review of Parkinson's disease from both clinical and scientific perspectives, covering its preclinical course, symptomatology, and genetic factors. It explores various subtypes and their implications for pathology, alongside diagnostic tools and treatment strategies, including traditional and novel therapies focused on neuroprotection and neuroregeneration. A significant highlight is the discussion on budipine, a new antiparkinsonian drug that affects non-dopaminergic systems. The text emphasizes the ongoing challenges and unanswered questions in effectively treating Parkinson's disease.